1. Home
  2. LPCN vs MOGU Comparison

LPCN vs MOGU Comparison

Compare LPCN & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • MOGU
  • Stock Information
  • Founded
  • LPCN 1997
  • MOGU 2011
  • Country
  • LPCN United States
  • MOGU China
  • Employees
  • LPCN N/A
  • MOGU N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • MOGU Business Services
  • Sector
  • LPCN Health Care
  • MOGU Consumer Discretionary
  • Exchange
  • LPCN Nasdaq
  • MOGU Nasdaq
  • Market Cap
  • LPCN 18.2M
  • MOGU 19.8M
  • IPO Year
  • LPCN N/A
  • MOGU 2018
  • Fundamental
  • Price
  • LPCN $3.19
  • MOGU N/A
  • Analyst Decision
  • LPCN Strong Buy
  • MOGU
  • Analyst Count
  • LPCN 1
  • MOGU 0
  • Target Price
  • LPCN $8.00
  • MOGU N/A
  • AVG Volume (30 Days)
  • LPCN 45.3K
  • MOGU 3.7M
  • Earning Date
  • LPCN 11-06-2025
  • MOGU 11-21-2025
  • Dividend Yield
  • LPCN N/A
  • MOGU N/A
  • EPS Growth
  • LPCN N/A
  • MOGU N/A
  • EPS
  • LPCN N/A
  • MOGU N/A
  • Revenue
  • LPCN $4,208,119.00
  • MOGU $19,462,964.00
  • Revenue This Year
  • LPCN N/A
  • MOGU N/A
  • Revenue Next Year
  • LPCN N/A
  • MOGU N/A
  • P/E Ratio
  • LPCN N/A
  • MOGU N/A
  • Revenue Growth
  • LPCN N/A
  • MOGU N/A
  • 52 Week Low
  • LPCN $2.65
  • MOGU $1.83
  • 52 Week High
  • LPCN $6.17
  • MOGU $8.10
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 63.61
  • MOGU 45.33
  • Support Level
  • LPCN $2.65
  • MOGU $3.11
  • Resistance Level
  • LPCN $3.52
  • MOGU $3.53
  • Average True Range (ATR)
  • LPCN 0.16
  • MOGU 0.24
  • MACD
  • LPCN 0.06
  • MOGU -0.13
  • Stochastic Oscillator
  • LPCN 67.24
  • MOGU 4.10

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About MOGU MOGU Inc.

MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.

Share on Social Networks: